NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.

Bitcoin and ether were little changed alongside softer U.S. equity futures as investors leaned risk-off. Some altcoins bucked ...

Targeted therapies, including BTK inhibitors and venetoclax, have replaced chemoimmunotherapy as the first-line standard for CLL, emphasizing patient preference and risk factors in treatment decisions ...

Crypto prices are recovering after tensions between the U.S. and its NATO allies eased in what's become known as a taco ...

The treatment has been approved for NHS use, offering new hope to the nearly 12,000 people in England living with lupus ...

Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by ...

Genmab plans to present full results at an upcoming medical meeting.

IBRX shares surge after updated data from the study of CD19 t-haNK show durable complete responses in Waldenstrom lymphoma ...

Dye-based internalization detection reagents distinguish surface-bound from internalized ADCs to support drug optimization.

The Food and Drug Administration (FDA) has approved Breyanzi ® (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) ...

Epkinly monotherapy significantly improved progression-free survival in relapsed/refractory DLBCL patients, reducing cancer ...

Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...